Akari Therapeutics Plc (AKTX) › Shares OutstandingAkari Therapeutics Plc (AKTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 12.10M2012: 13.37M2013: 40.23M2014: 722.35M2015: 1.18B2016: 1.18B2017: 1.53B2018: 312.0K2019: 2.25B2020: 3.85B2021: 4.76B2022: 7.44B2023: 13.23B2024: 53.19B2025: 90.54B90.54B2011Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202590.54B+70.2%202453.19B+301.9%202313.23B+77.8%20227.44B+56.4%20214.76B+23.7%20203.85B+71.3%20192.25B+719685.0%2018312.0K-100.0%20171.53B+29.5%20161.18B+0.0%20151.18B+63.0%2014722.35M+1695.6%201340.23M+200.9%201213.37M+10.5%201112.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share